Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00419393 · ClinicalTrials.gov registry record · Phase 3

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

A Phase 3 study of Epilepsy, sponsored by UCB Pharma.

Completed
Registry status
Phase 3
Development phase
190
Enrollment target
20
Study locations

NCT00419393 is a Phase 3 study of Epilepsy that has completed, run by UCB Pharma. The registered enrollment target is 190 participants, below the 951-participant average among 160 other Epilepsy trials with a reported enrollment target (80% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00419393, a Phase 3 study of Epilepsy, has completed, sponsored by UCB Pharma.

COMPLETED
Registry status
Phase 3
Development phase
190 participants
Enrollment target
20
Study locations

Study Summary

To provide continued treatment of Keppra XR (Levetiracetam XR) and to assess the long term safety of Keppra XR in subjects with partial onset seizures.

Conditions Studied

Epilepsy

Interventions

  • DRUG Keppra XR (Levetiracetam XR)

Study Locations (20)

Other

  • - Aguascalientes
  • - Guadalajara
  • - Guadalajara Jalisco
  • - Mexico City

Alabama

  • - Dothan
  • - Northport

Georgia

  • - Atlanta
  • - Suwanee

New York

  • - Buffalo
  • - Cedarhurst

Arizona

  • - Phoenix

Arkansas

  • - Little Rock

California

  • - Bakersfield

Florida

  • - Loxahatchee Groves

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2007-12
Est. Completion 2010-03
Phase Phase 3

Sponsor

UCB Pharma

100 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00419393

The ClinicalTrials.gov registry entry for NCT00419393 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 951-participant average among 160 other Epilepsy trials with a reported enrollment target (80% lower). The listed sponsor is UCB Pharma, which has 100 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Keppra XR (Levetiracetam XR) is the first listed.

NCT00419393 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Other, Alabama, Georgia.

Frequently Asked Questions

What is clinical trial NCT00419393 about?

NCT00419393 is a clinical study titled "Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures". To provide continued treatment of Keppra XR (Levetiracetam XR) and to assess the long term safety of Keppra XR in subjects with partial onset seizures.

What is the current status of trial NCT00419393?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 190 participants. The study started on 2007-12. Estimated completion is 2010-03.

What conditions does trial NCT00419393 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT00419393?

The interventions under investigation include: Keppra XR (Levetiracetam XR) (DRUG).

Who is sponsoring clinical trial NCT00419393?

This trial is sponsored by UCB Pharma, which has 100 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00419393 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Epilepsy

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.